Lawyers and Settlements
Advertisement

Lucy Campbell

A freelance writer for nearly two decades, Lucy Campbell has traveled extensively, covering stories of interest from around the world. Much of Lucy's focus is on consumer advocacy, and the legal topics that affect her readers' daily lives--everything from mislabeled food to auto recalls to harmful drugs and defective products. In her spare time, Lucy enjoys painting and a good cup of coffee.


$247M Verdict for Plaintiffs In DePuy Pinnacle Hip Replacement Trial

November 16, 2017.
Dallas, TX: A $247 million verdict has been awarded against the maker of DePuy’s Pinnacle line of metal-on-metal hip implants, DePuy Orthopaedics Inc, and its parent company Johnson & Johnson (J&J), with $90 million in punitive damages against J&J and $78 million in punitive damages against DePuy. The settlement is the third, consecutive multi-million dollar verdict delivered in this multidistrict litigation.
Read [ $247M Verdict for Plaintiffs In DePuy Pinnacle Hip Replacement Trial ]

New Risperdal Trial Ordered

November 15, 2017.
Philadelphia, PA: The makers of Risperdal, Janssen Pharmaceuticals and its parent company Johnson & Johnson (J&J) must face a retrial of a lawsuit alleging their anti-psychotic drug Risperdal caused the plaintiff, a young man referred to as WC, to grow female-like breasts.
Read [ New Risperdal Trial Ordered ]

First Xarelto Trial Stalled Over Allegations of Witness Tampering

November 6, 2017.
Philadelphia, PA: Allegations of witness tampering have stalled the beginning of the Xarelto litigation. The first Xarelto trail was set to being Monday, November 6, but instead got sidelined by attempts to determine the significance of a meeting between a key witness, Dr. Timothy Aldridge, the plaintiff’s treating physician, and a Janssen sales representative.
Read [ First Xarelto Trial Stalled Over Allegations of Witness Tampering ]

Don't Use Ultrasonic Aspirators to Remove Uterine Fibroids FDA States

October 31, 2017.
Washington, DC: The US Food and Drug Administration (FDA) has provided the medical community with guidance on the use of ultrasonic surgical aspirators. Specifically, the agency is advising companies that make the devices to label them as contraindicated for the removal of uterine fibroids. The non-binding guidance from the agency serves to strengthen its recent warnings about the use of power morcellators to remove uterine fibroids.
Read [ Don't Use Ultrasonic Aspirators to Remove Uterine Fibroids FDA States ]

$417 Jury Verdict Tossed in California J&J Ovarian Cancer Lawsuit

October 23, 2017.
Los Angeles, CA: Another multi-million dollar jury verdict awarded to a woman who alleged she developed ovarian cancer from using Johnson & Johnson Baby Powder has been tossed by a California Judge.
Read [ $417 Jury Verdict Tossed in California J&J Ovarian Cancer Lawsuit ]

$72M J&J Talc Cancer Verdict Reversed

October 18, 2017.
Jefferson City, MO: A $72 million verdict in favor of the family of a woman whose death from ovarian cancer was allegedly linked to her long term use of Johnson and Johnson’s Baby Powder has been reversed by The Missouri Court of Appeals for the Eastern District.
Read [ $72M J&J Talc Cancer Verdict Reversed ]

Androgel Heart Attack Victim Awarded $140M

October 11, 2017.
Chicago, IL: AbbiVie, maker of the testosterone replacement therapy AndroGel, has been ordered to pay over $140 million to a man who alleges he suffered a heart attack as a result of using the drug.
Read [ Androgel Heart Attack Victim Awarded $140M ]

Bayer Pulls Essure Birth Control Device From All Countries Except US

September 26, 2017.
Washington, DC: Bayer has announced that it is taking its female sterilization device, Essure, off the market in all countries where it is currently marketed and sold, except the US. The company said it was taking this action due to commercial reasons, and not because of allegations of side effects associated with the device.
Read [ Bayer Pulls Essure Birth Control Device From All Countries Except US ]

FDA Clears Bair Hugger for Post-Surgical Use

September 12, 2017.
Washington, DC: 3M’s , Bair Hugger, the subject of some 2600 defective products lawsuits across the US, has received clearance for use from the US Food and Drug Administration (FDA). According to a spokesperson for the FDA, the agency has no conclusive evidence to establish an association between use of a forced air thermal regulating systems and an increased risk of surgical-site infections.
Read [ FDA Clears Bair Hugger for Post-Surgical Use ]

$57.1M Ethicon TVT Secur Mesh Verdict Awarded

September 8, 2017.
Philadelphia, PA: A $57.1 million verdict has been awarded against the makers of defective TVT Secur mesh, Johnson & Johnson and its subsidiary, Ethicon. The award breaks down as $50 million in punitive damages and $7.1 million in compensatory damages for plaintiff Ella Ebaugh, a Pennsylvania resident, according to court documents.
Read [ $57.1M Ethicon TVT Secur Mesh Verdict Awarded ]

Page: 1  2  3  4  5  6  7  8  9  -  10»  -  22   Next»

Request Legal Help

First name:

Last name:

Email address:

Phone number(s):

Zip/Postal Code:

Defendant:
Describe your complaint:

Category:
By submitting this form I agree to the Terms of Service.
There is no cost to submit this form.
I would like to be interviewed by a journalist.
Receive our weekly newsletter with the latest lawsuit news and legal information.


Legal Services:

Advertisement
 
FAQ | TOS | Privacy | Disclaimer | About Us | Contact Us | Press | Advertise | Member Login | Site Map | View Mobile Website

American Bar Association - Proud Member   Better Business Bureau   CAALA   Best of the Web Approved   Public Justice


This work is licensed under a Creative Commons Attribution-NoDerivs 3.0 Unported License © 2001-2017 Online Legal Media. All rights reserved.


Visit other Online Legal Media Websites:

BigClassAction.comCALaborLawNews.com
OnlineLegalMarketing.comHealthEffectsOfAsbestos.com